Erythrocyte-aggregating relapsing fever spirochete Borrelia crocidurae induces formation of microemboli

Journal of Infectious Diseases

Volumn 180, Issue 6, 1999, Pages 1929-1938

  Shamaei Tousi, Alireza ^a   Martin, Pierre ^a   Bergh, Anders ^a   Burman, Nils ^a   Brännström, Thomas ^a   Bergström, Sven ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BORRELIA; BORRELIA INFECTION; ERYTHROCYTE AGGREGATION; HISTOPATHOLOGY; INFLAMMATORY DISEASE; MICROEMBOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BORRELIA; BRAIN; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EMBOLISM; ERYTHROCYTE AGGREGATION; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; KIDNEY; LUNG; MENINGOENCEPHALITIS; MICE; MICE, INBRED BALB C; RELAPSING FEVER; SILVER STAINING;

EID: 0032736603     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315118     Document Type: Article

References (54)

1. 1. Burgdorfer W. The epidemiology of the relapsing fevers. In: Johnson ERC, ed. Biology of parasitic spirochetes. New York: Academic Press, 1976: 191-200.
2. 2. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP. Lyme disease - a tick-borne spirochetosis? Science 1982; 216:1317-9.
3. 3. Cutler SJ, Moss J, Fukunaga M, Wright DJ, Fekade D, Warrell D. Borrelia recurrentis characterization and comparison with relapsing-fever, Lyme-associated, and other Borrelia spp. Int J Syst Bacteriol 1997; 47:958-68.
4. 4. Felsenfeld O. Borrelia, human relapsing fever, and parasite-vector-host relationships. Bacteriol Rev 1965; 342:1213-5.
5. 5. Sundnes KO, Haimanot AT. Epidemic of louse-borne relapsing fever in Ethiopia. Lancet 1993; 342:1213-5.
6. 6. Trape JF, Duplantier JM, Bouganali H, et al. Tick-borne borreliosis in west Africa. Lancet 1991; 337:473-5.
7. 7. Dupont HT, La Scola B, Williams R, Raoult D. A focus of tick-borne relapsing fever in southern Zaire. Clin Infect Dis 1997; 25:139-44.
8. 8. Felsenfeld O. Borrelia: strains, vectors, human and animal borreliosis. St. Louis: Warren H. Green, 1968.
9. 9. Southern P, Sanford J. Relapsing fever: a clinical and microbiological review. Medicine 1969; 48:129-49.
10. 10. Stoenner HG, Dodd T, Larsen C. Antigenic variation or Borrelia hermsii. J Exp Med 1982; 156:1297-311.
11. 11. Barstad PA, Coligan JE, Raum MG, Barbour AG. Variable major proteins of Borrelia hermsii. Epitope mapping and partial sequence analysis of CNBr peptides. J Exp Med 1985; 161:1302-14.
12. 12. Burman N, Bergstrom S, Restrepo BI, Barbour AG. The variable antigens Vmp7 and Vmp21 of the relapsing fever bacterium Borrelia hermsii are structurally analogous to the VSG proteins of the African trypanosome. Mol Microbiol 1990; 4:1715-26.
13. 13. Bryceson AD, Parry EH, Perine PL, Warrell DA, Vukotich D, Leithead CS. Louse-borne relapsing fever. Q J Med 1970; 39:129-70.
14. 14. Butler T, Hazen P, Wallace CK, Awoke S, Habte-Michael A. Infection with Borrelia recurrentis: pathogenesis of fever and petechiae. J Infect Dis 1979; 140:665-75.
15. 15. Butler T, Spagnuolo PJ, Goldsmith GH, Aikawa M. Interaction of Borrelia spirochetes with human mononuclear leukocytes causes production of leukocytic pyrogen and thromboplastin. J Lab Clin Med 1982; 99:709-21.
16. 16. Wengrower D, Knobler H, Gillis S, Chajek-Shaul T. Myocarditis in tick-borne relapsing fever. J Infect Dis 1984; 149:1033.
17. 17. Bergeret C, Raoult A. Notes sur les formes nerveuses de la fievre recurrente - fievre recurrente a tiques en Afrique Occidentale Francaise. Bull Med Afrique Occidentale Francaise 1948; 5:271-9.
18. 18. Levaditi C, Anderson T. Neurotropisme du Spirochaeta duttoni. Comptes Rendus Acad Sci 1928; 186:653-4.
19. 19. Scott R. Neurological complications of relapsing fever. Lancet 1944; 247: 436-8.
20. 20. Taft W, Pike J. Relapsing fever. Report of a sporadic outbreak including treatment with penicillin. JAMA 1945; 129:1002-5.
21. 21. Olchovsky D, Pines A, Sadeh M, Kaplinsky N, Frankl O. Multifocal neuropathy and vocal cord paralysis in relapsing fever. Eur Neurol 1982; 21: 340-2.
22. 22. Goubau PF. Relapsing fevers. A review. Ann Soc Belgian Med Trop 1984; 64:335-64.
23. 23. Anda P, Sanchez-Yebra W, del Mar Vitutia M, et al. A new Borrelia species isolated from patients with relapsing fever in Spain. Lancet 1996; 348: 162-5.
24. 24. Garcia-Monco JC, Miller NS, Backenson PB, Anda P, Benach JL. A mouse model of Borrelia meningitis after intradermal injection. J Infect Dis 1997; 175:1243-5.
25. 25. Gebbia JA, Monco JC, Degen JL, Bugge TH, Benach JL. The plasminogen activation system enhances brain and heart invasion in murine relapsing fever borreliosis. J Clin Invest 1999; 103:81-7.
26. 26. Aubry P, Renambot J, Teyssier J, et al. Borreliosis caused by ticks in Senegal; apropos of 23 cases. Dakar Med 1983; 28:413-20.
27. 27. Colebunders R, De Serrano P, Van Gompel A, et al. Imported relapsing fever in European tourists. Scand J Infect Dis 1993; 25:533-6.
28. 28. Mooser H. Die Rückfallfieber. Ergeb Mikrobiol 1958; 31:184-229.
29. 29. Mooser H. Erytrozyten-adhäsion und hämagglomeration durch rückfallfieber-spirochäten. Tropenmed Parasitol 1958; 9:93-111.
30. 30. Burman N, Shamaei-Tousi A, Bergstrom S. The spirochete Borrelia crocidurae causes erythrocyte rosetting during relapsing fever. Infect Immun 1998; 66:815-9.
31. 31. Barbour AG. Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med 1984; 57:521-5.
32. 32. Tsirka SE, Gualandris A, Amaral DG, Strickland S. Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator, Nature 1995; 377:340-4.
33. 33. Judge DM, La Croix JT, Ferine PL. Experimental louse-borne relapsing fever in the grivet monkey, Cercopithecus aethiops. II. Pathology. Am J Trop Med Hyg 1974; 23:962-8.
34. 34. Judge DM, Samuel I, Perine PL, Vukotic D, Ababa A. Louse-borne relapsing fever in man. Arch Pathol 1974; 97:136-70.
35. 35. Cadavid D, Thomas DD, Crawley R, Barbour AG. Variability of a bacterial surface protein and disease expression in a possible mouse model of systemic Lyme borreliosis. J Exp Med 1994; 179:631-42.
36. 36. Cadavid D, Barbour AG. Neuroborreliosis during relapsing fever: review of the clinical manifestations, pathology, and treatment of infections in humans and experimental animals. Clin Infect Dis 1998; 26:151-64.
37. 37. Cadavid D, Bundoc V, Barbour AG. Experimental infection of the mouse brain by a relapsing fever Borrelia species: a molecular analysis. J Infect Dis 1993; 168:143-51.
38. 38. Peters DJ, Benach JL. Borrelia burgdorferi adherence and injury to undifferentiated and differentiated neural cells in vitro. J Infect Dis 1997; 176: 470-7.
39. 39. Garcia Monco JC, Fernandez Villar B, Rogers RC, Szczepanski A, Wheeler CM, Benach JL. Borrelia burgdorferi and other related spirochetes bind to galactocerebroside. Neurology 1992; 42:1341-8.
40. 40. Garcia-Monco JC, Fernandez-Villar B, Benach JL. Adherence of the Lyme disease spirochete to glial cells and cells of glial origin. J Infect Dis 1989; 160:497-506.
41. 41. Kumar V, Cotran RS, Robins SL. Basic pathology. 5th ed. New York: W. B. Saunders, 1992.
42. 42. Galbe JL, Guy E, Zapatero JM, Peerschke EI, Benach JL. Vascular clearance of Borrelia burgdorferi in rats. Microb Pathog 1993; 14:187-201.
43. 43. Coburn J, Leong JM, Erban JK. Integrin alpha IIb beta 3 mediates binding of the Lyme disease agent Borrelia burgdorferi to human platelets. Proc Natl Acad Sci USA 1993; 90:7059-63.
44. 44. Coburn J, Barthold SW, Leong JM. Diverse Lyme disease spirochetes bind integrin alpha IIb beta 3 on human platelets. Infect Immun 1994; 62: 5559-67.
45. 45. Curwen KD, Gimbrone MA Jr, Handin RI. In vitro studies of thrombo-resistance: the role of prostacyclin (PGI2) in platelet adhesion to cultured normal and virally transformed human vascular endothelial cells. Lab Invest 1980; 42:366-74.
46. 46. Bae SK, Baek JH, Lee YM, Lee OH, Kim KW. Hypoxia-induced apoptosis in human hepatocellular carcinoma cells: a possible involvement of the 6-TG-sensitive protein kinase(s)-dependent signaling pathway. Cancer Lett 1998; 126:97-104.
47. 47. Carmeliet P, Dor Y, Herbert JM, et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation, and tumour angiogenesis. Nature 1998; 394:485-90.
48. 48. Barclay AJ, Coulter JB. Tick-borne relapsing fever in central Tanzania. Trans R Soc Trop Med Hyg 1990; 84:852-6.
49. 49. Mekasha A, Meharie S. Outbreak of louse-borne relapsing fever in Jimma, south western Ethiopia. East Afr Med J 1996; 73:54-8.
50. 50. Abdalla RE. Some studies on relapsing fever in the Sudan. J Trop Med Hyg 1969; 72:125-8.
51. 51. Garcia-Monco JC, Benach JL. Lyme neuroborreliosis. Ann Neurol 1995; 37: 691-702.
52. 52. Steere AC. Lyme disease. N Engl J Med 1989; 321:586-96.
53. 53. Barthold SW, Persing DH, Armstrong AL, Peeples RA. Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice. Am J Pathol 1991; 139:263-73.
54. 54. David PH, Handunnetti SM, Leech JH, Gamage P, Mendis KN. Rosetting: a new cytoadherence property of malaria-infected erythrocytes. Am J Trop Med Hyg 1988; 38:289-97.